Table 3.
Comparison of Some Prognostic Factors of HCC According to the Positivity of EPCAM
| EpCAM neg (n 61) | EpCAM pos (n 13) | Chi square | P value | ||
|---|---|---|---|---|---|
| Sex | Males | 40 | 11 | ||
| Females | 21 | 2 | 1.1 | 0.31 | |
| Distant | Present | 7 | 7 | ||
| metastasis | Absent | 54 | 6 | 9.9 | 0.002* |
| Lymph node | Present | 9 | 11 | ||
| metastasis | Absent | 52 | 2 | 23.1 | <0.001* |
| PVT | Present | 2 | 8 | ||
| Absent | 59 | 5 | 26.3 | <0.001* | |
| Cirrhosis | Present | 15 | 7 | ||
| Absent | 46 | 6 | 3.1 | 0.078 | |
| Hepatitis | Present | 16 | 3 | ||
| Absent | 45 | 10 | 0.01 | 0.92 | |
| Stage | I | 11 | 2 | ||
| II | 27 | 8 | |||
| III | 15 | 3 | |||
| IV | 8 | 0 | 0 | 1 | |
| IV | 8 | 0 | 0 | 1 |
*, Significant; EpCAM, Epithelial cell adhesion molecule; PVT, Portal vein thrombosis.